Joel Bez, DO
Interventional Pain Medicine · Portage, MINPI 1821060427
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 344 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 81.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $1,626 and has fallen 98.8% since, to $19 in 2025.
Across 344 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Nevro Corp.$270
- Si-bone, Inc.$186
- Boston Scientific$164
- Medtronic$121
- Assertio Therapeutics, Inc.$82
- plus $417 from 11 others
What the payments were for
- Food & beverage$6,804100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 293 | $5,578 |
| Nevro Corp. | 6 | $270 |
| Si-bone, Inc. | 3 | $186 |
| Boston Scientific | 5 | $164 |
| Medtronic(2 entities) | 6 | $121 |
| Assertio Therapeutics, Inc. | 6 | $82 |
| Amgen(2 entities) | 5 | $80 |
| Lilly USA, LLC | 4 | $56 |
| Collegium Pharmaceutical, Inc. | 3 | $48 |
| Pacira Therapeutics, Inc. | 3 | $47 |
| Painteq LLC | 2 | $45 |
| AbbVie | 3 | $45 |
| GRT US Holding, Inc. | 1 | $21 |
| Bioventus LLC | 1 | $21 |
| Pfizer | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$598
- OCTRODE$521
- Senza$138
- PROCLAIM$130
- Proclaim IPG$123
How this compares
$6,818 in reported general payments places this provider in the 75th percentile of 88 interventional pain medicine providers in Michigan.
See all interventional pain medicine providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 12 | $1,299 |
| Gabapentin | 94 | $1,019 |
| Pregabalin | 50 | $808 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $552 |
| Tizanidine Hcl | 59 | $520 |
| Diclofenac Sodium | 26 | $347 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $265 |
| Cyclobenzaprine Hcl | 30 | $239 |
| Duloxetine Hcl | 21 | $188 |
| Tramadol Hcl | 27 | $172 |
| Ibuprofen | 11 | $108 |
| Meloxicam | 19 | $43 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Portage
- Barton WildPortage$7K
- Matthew KuiperPortage$3K
- Ryan PollinaSaint Clair Shores$144K
- Ariel MajjhooMonroe$124K
- Chad BrummettAnn Arbor$109K
- Anand ThakurClinton Township$102K
- Evan PeskinFlint$72K
- Richard FerroLansing$31K
- John ChatasAnn Arbor$29K
- Bryant IttiaraAllen Park$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.